<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29891884</article-id>
<article-id pub-id-type="pmc">6138627</article-id>
<article-id pub-id-type="publisher-id">196</article-id>
<article-id pub-id-type="doi">10.1038/s41431-018-0196-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expanding the clinical and molecular findings in <italic>RASA1</italic> capillary malformation-arteriovenous malformation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wooderchak-Donahue</surname>
<given-names>Whitney L.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Johnson</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDonald</surname>
<given-names>Jamie</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blei</surname>
<given-names>Francine</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berenstein</surname>
<given-names>Alejandro</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sorscher</surname>
<given-names>Michelle</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mayer</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scheuerle</surname>
<given-names>Angela E.</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Tracey</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grimmer</surname>
<given-names>J. Fredrik</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Richter</surname>
<given-names>Gresham T.</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steeves</surname>
<given-names>Marcie A.</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Angela E.</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stevenson</surname>
<given-names>David A.</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bayrak-Toydemir</surname>
<given-names>Pinar</given-names>
</name>
<address>
<phone>+801-583-2787</phone>
<email>pinar.bayrak-toydemir@aruplab.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution>ARUP Institute for Clinical and Experimental Pathology, </institution></institution-wrap>Salt Lake City, UT USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution>Department of Pathology, </institution><institution>University of Utah, </institution></institution-wrap>Salt Lake City, UT USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution>HHT Center, Department of Radiology, </institution><institution>University of Utah, </institution></institution-wrap>Salt Lake City, UT USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution>Vascular Anomalies Program of Lenox Hill Hospital, Northwell Health, </institution><institution>Hofstra School of Medicine, </institution></institution-wrap>New York City, NY USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9963 6690</institution-id><institution-id institution-id-type="GRID">grid.425214.4</institution-id><institution>Pediatric Endovascular Surgery Ichan School of Medicine, </institution><institution>Mt. Sinai Health System, </institution></institution-wrap>New York City, NY USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0467 2330</institution-id><institution-id institution-id-type="GRID">grid.413611.0</institution-id><institution>Department of Pediatric Hematology and Oncology, </institution><institution>All Children’s Hospital Johns Hopkins Medicine, </institution></institution-wrap>St. Petersburg, FL USA </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution>Department of Pediatrics, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution>Division of Otolaryngology, Department of Surgery, </institution><institution>University of Utah, </institution></institution-wrap>Salt Lake City, UT USA </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4687 1637</institution-id><institution-id institution-id-type="GRID">grid.241054.6</institution-id><institution>Department of Otolaryngology-Head and Neck Surgery, </institution><institution>University of Arkansas for Medical Sciences, </institution></institution-wrap>Little Rock, AR USA </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution>Medical Genetics, </institution><institution>Mass General Hospital for Children, </institution></institution-wrap>Boston, MA USA </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Division of Medical Genetics, Department of Pediatrics, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>26</volume>
<issue>10</issue>
<fpage>1521</fpage>
<lpage>1536</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© European Society of Human Genetics 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1"><italic>RASA1</italic>-related disorders are vascular malformation syndromes characterized by hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM), arteriovenous fistulas (AVF), or Parkes Weber syndrome. The number of cases reported is relatively small; and while the main clinical features are CMs and AVMs/AVFs, the broader phenotypic spectrum caused by variants in the <italic>RASA1</italic> gene is still being defined. Here, we report the clinical and molecular findings in 69 unrelated cases with a <italic>RASA1</italic> variant identified at ARUP Laboratories. Sanger sequencing and multiplex ligation-dependent probe amplification were primarily used to evaluate <italic>RASA1</italic>. Several atypical cases were evaluated using next-generation sequencing (NGS) and array-comparative genomic hybridization (aCGH). Sixty individuals had a deleterious <italic>RASA1</italic> variant of which 29 were novel. Nine individuals had a variant of uncertain significance. Five large <italic>RASA1</italic> deletions were detected, giving an overall deletion/duplication rate of 8.3% (5/60) among positive cases. Most (75.4%) individuals with a <italic>RASA1</italic> variant had CMs, and 44.9% had an AVM/AVF. Clinical findings in several cases expand the <italic>RASA1</italic> phenotype. Our data suggest that screening for large <italic>RASA1</italic> deletions and duplications in this disorder is important and suggest that NGS multi-gene panel testing is beneficial for the molecular diagnosis of cases with complex vascular phenotypes.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© European Society of Human Genetics 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>